Regulatory Spine Top Stories VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression byJosh SandbergSeptember 29, 2026
Biologics Regulatory Spine VB Spine Receives FDA Clearances of Expanded Indications for Vitoss® Bone Graft Substitute and Interbody Cage Portfolio byTim AllenJuly 29, 2026
Spine VB Spine’s European Distribution Center Begins Shipping Orders Across Europe byJosh SandbergJuly 9, 2026
Spine VB Spine to Acquire CT-Fluoro Technology for Spine Applications from Augmedics byJosh SandbergJuly 7, 2026
Spine Top Stories VB Spine Funds Landmark Research to Deliver the First Predictive Blood Test for Scoliosis in Adolescents byTim AllenJune 5, 2026
Spine Top Stories VB Spine Completes Transaction of Augmented Reality Spine Platform from Augmedics byJosh SandbergApril 13, 2026
Spine Top Stories VB Spine Announces Successful First Clinical Cases of Vulcan™ Spinal System byTim AllenMarch 10, 2026
Spine Top Stories VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform byJosh SandbergFebruary 16, 2026
Spine VB Spine to Acquire Intraoperative Visualization Platform From Robotron Surgical Technologies byTim AllenJanuary 15, 2026
